These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27648827)

  • 1. Association between P16INK4a Promoter Methylation and Ovarian Cancer: A Meta-Analysis of 12 Published Studies.
    Xiao X; Cai F; Niu X; Shi H; Zhong Y
    PLoS One; 2016; 11(9):e0163257. PubMed ID: 27648827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between P16INK4a promoter methylation and HNSCC: a meta-analysis of 21 published studies.
    Shi H; Chen X; Lu C; Gu C; Jiang H; Meng R; Niu X; Huang Y; Lu M
    PLoS One; 2015; 10(4):e0122302. PubMed ID: 25835498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis demonstrates no association between p16
    Jiang Y; Yan F; Liang L; Wan Y; Liu J; Cheng W
    Arch Gynecol Obstet; 2017 Mar; 295(3):697-704. PubMed ID: 28000027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between RASSF1A promoter methylation and ovarian cancer: a meta-analysis.
    Shi H; Li Y; Wang X; Lu C; Yang L; Gu C; Xiong J; Huang Y; Wang S; Lu M
    PLoS One; 2013; 8(10):e76787. PubMed ID: 24116157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Disfigurement of p16INK4A gene expression in development of ovarian cancer and the mechanism].
    Li M; Huang ZJ; Dong WH; Li XY; Wang XY; He XH; Wang H; Wang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):408-12. PubMed ID: 16831366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation and messenger RNA expression of p15INK4b but not p16INK4a are independent risk factors for ovarian cancer.
    Liu Z; Wang LE; Wang L; Lu KH; Mills GB; Bondy ML; Wei Q
    Clin Cancer Res; 2005 Jul; 11(13):4968-76. PubMed ID: 16000597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bronchial lavage P 16INK4A gene promoter methylation and lung cancer diagnosis: A meta-analysis.
    Yifan D; Qun L; Yingshuang H; Xulin L; Jianjun W; Qian M; Yuman Y; Zhaoyang R
    Indian J Cancer; 2015 Dec; 52 Suppl 2():e96-8. PubMed ID: 26728683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter methylations of p16INK4a and p14ARF genes in early and advanced gastric cancer. Correlations of the modes of their occurrence with histologic type.
    Tsujimoto H; Hagiwara A; Sugihara H; Hattori T; Yamagishi H
    Pathol Res Pract; 2002; 198(12):785-94. PubMed ID: 12608655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Effects of RASSF1A, BRCA1, APC, and p16 Promoter Methylation in Ovarian Cancer: A Meta-Analysis.
    Chen C; Zhu Y; Zhang H; Xiao L
    Gynecol Obstet Invest; 2024; 89(5):363-375. PubMed ID: 38615670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation and aberrant promoter methylation of p16INK4A: a possible novel heritable susceptibility marker to retinoblastoma.
    Indovina P; Acquaviva A; De Falco G; Rizzo V; Onnis A; Luzzi A; Giorgi F; Hadjistilianou T; Toti P; Tomei V; Pentimalli F; Carugi A; Giordano A
    J Cell Physiol; 2010 Apr; 223(1):143-50. PubMed ID: 20039270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of mutation at p16INK4A gene but expression of aberrant p16INK4A RNA transcripts in human ovarian carcinoma.
    Suh SI; Cho JW; Baek WK; Suh MH; Carson DA
    Cancer Lett; 2000 May; 153(1-2):175-82. PubMed ID: 10779647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships between p16 gene promoter methylation and clinicopathologic features of colorectal cancer: a meta-analysis of 27 cohort studies.
    Chen YZ; Liu D; Zhao YX; Wang HT; Gao Y; Chen Y
    DNA Cell Biol; 2014 Oct; 33(10):729-38. PubMed ID: 24979649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation of p16INK4A in primary gynecologic malignancy.
    Wong YF; Chung TK; Cheung TH; Nobori T; Yu AL; Yu J; Batova A; Lai KW; Chang AM
    Cancer Lett; 1999 Mar; 136(2):231-5. PubMed ID: 10355753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and prognostic effects of
    Xia L; Zhang W; Gao L
    Biomarkers; 2019 Nov; 24(7):700-711. PubMed ID: 31382782
    [No Abstract]   [Full Text] [Related]  

  • 15. The association between CDH1 promoter methylation and patients with ovarian cancer: a systematic meta-analysis.
    Wang Q; Wang B; Zhang YM; Wang W
    J Ovarian Res; 2016 Apr; 9():23. PubMed ID: 27067410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDKN2A promoter methylation and hepatocellular carcinoma risk: A meta-analysis.
    Zhou Y; Wang XB; Qiu XP; Shuai Zhang ; Wang C; Zheng F
    Clin Res Hepatol Gastroenterol; 2018 Dec; 42(6):529-541. PubMed ID: 30143452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic alteration of p16INK4a gene in dedifferentiation of liposarcoma.
    He M; Aisner S; Benevenia J; Patterson F; Harrison LE; Hameed M
    Pathol Res Pract; 2009; 205(6):386-94. PubMed ID: 19186005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P16
    Tuo L; Sha S; Huayu Z; Du K
    Thorac Cancer; 2018 Aug; 9(8):1032-1040. PubMed ID: 29927090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypermethylation of the p16INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis.
    Hsieh CJ; Klump B; Holzmann K; Borchard F; Gregor M; Porschen R
    Cancer Res; 1998 Sep; 58(17):3942-5. PubMed ID: 9731506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p16 gene alterations in human ovarian cancers: comparison between tissue and blood samples.
    Bammidi LS; Neerukonda GN; Murthy S; Kanapuram RD
    Int J Gynecol Cancer; 2012 May; 22(4):553-60. PubMed ID: 22344043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.